Safe use of citric acid-based dialysate and heparin removal in postdilution online hemodiafiltration

Blood Purification

Volumn 34, Issue 3-4, 2013, Pages 336-343

  Aniort, Julien ^a   Petitclerc, Thierry ^a,b   Créput, Caroline ^a  

^a AURA   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Anticoagulation; Biocompatibility; Citratemia; Citric acid based dialysate; Dialysis efficiency; Hemodiafiltration; Ionized calcemia; Parathyroid hormone

Indexed keywords

BETA 2 MICROGLOBULIN; BICARBONATE; CALCIUM; CITRIC ACID; ENOXAPARIN; HEPARIN; HYDROCHLORIC ACID; PARATHYROID HORMONE; PHOSPHATE;

ADULT; AGED; ANTICOAGULATION; ARTERIOVENOUS FISTULA; ARTERIOVENOUS FISTULA STENOSIS; ARTICLE; BLOOD CLOTTING; CITRIC ACID BASED DIALYSATE; CLINICAL ARTICLE; DIALYSATE; DILUTION; FEMALE; HEMODIALYSIS; HUMAN; MALE; POSTDILUTION ONLINE HEMODIAFILTRATION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGED; BLOOD CHEMICAL ANALYSIS; BLOOD COAGULATION; CITRIC ACID; FEMALE; HEMODIAFILTRATION; HEMODIALYSIS SOLUTIONS; HEPARIN; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84872074167     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000345342     Document Type: Article

References (20)

1. Hottelart C, Achard JM, Moriniere P, et al: Heparin-induced hyperkalemia in chronic hemodialysis patients: comparison of low molecular weight and unfractionated heparin. Artif Organs 1998; 22: 614-617. (Pubitemid 28324038)
2. Mahmood D, Grubbstrom M, Lundberg LD, et al: Lipoprotein lipase responds similarly to tinzaparin as to conventional heparin during hemodialysis. BMC Nephrol 2010; 11: 33.
3. Nelson-Piercy C: Heparin-induced osteoporosis. Scand J Rheumatol Suppl 1998; 107: 68-71. (Pubitemid 28432949)
4. Tu AA: S heparin-free hemodialysis with citrate- containing dialysate in intensive care patients. Dial Transplant 2000; 29: 620-626.
5. Apsner R, Buchmayer H, Gruber D, et al: Citrate for long-term hemodialysis: prospective study of 1,009 consecutive high-flux treatments in 59 patients. Am J Kidney Dis 2005; 45: 557-564. (Pubitemid 40341335)
6. Ahmad S, Callan R, Cole JJ, et al: Dialysate made from dry chemicals using citric acid increases dialysis dose. Am J Kidney Dis 2000; 35: 493-499.
7. Bauer E, Derfler K, Joukhadar C, et al: Citrate kinetics in patients receiving long-term hemodialysis therapy. Am J Kidney Dis 2005; 46: 903-907. (Pubitemid 41505465)
8. Kossmann RJ, Gonzales A, Callan R, et al: Increased efficiency of hemodialysis with citrate dialysate: a prospective controlled study. Clin J Am Soc Nephrol 2009; 4: 1459-1464.
9. Gabutti L, Lucchini B, Marone C, et al: Citrate- vs. acetate-based dialysate in bicarbonate haemodialysis: consequences on haemodynamics, coagulation, acid-base status, and electrolytes. BMC Nephrol 2009; 10: 7.
10. Kuragano T, Kida A, Furuta M, et al: Effects of acetate-free citrate-containing dialysate on metabolic acidosis, anemia, and malnutrition in hemodialysis patients. Artif Organs 2012; 36: 282-290.
11. Sands JJ, Kotanko P, Segal JH, et al: Effects of citrate acid concentrate (Citrasate) on heparin N requirements and hemodialysis adequacy: a multicenter, prospective noninferiority trial. Blood Purif 2012; 33: 199-204.
12. Lornoy W, Becaus I, Billiouw JM, et al: Remarkable removal of beta-2-microglobulin by on-line hemodiafiltration. Am J Nephrol 1998; 18: 105-108. (Pubitemid 28161815)
13. Bolasco P, Altieri P, Andrulli S, et al: Convection versus diffusion in dialysis: an Italian prospective multicentre study. Nephrol Dial Transplant 2003; 18(suppl 7):vii50-vii54, discussion vii59-vii62. (Pubitemid 37098610)
14. Klingel R, Schaefer M, Schwarting A, et al: Comparative analysis of procoagulatory activity of haemodialysis, haemofiltration and haemodiafiltration with a polysulfone membrane (Aps) and with different modes of enoxaparin anticoagulation. Nephrol Dial Transplant 2004; 19: 164-170. (Pubitemid 38072628)
15. Bakker AJ, Boerma EC, Keidel H, et al: Detection of citrate overdose in critically ill patients on citrate-anticoagulated venovenous haemofiltration: use of ionised and total/ ionised calcium. Clin Chem Lab Med 2006; 44: 962-966. (Pubitemid 44155864)
16. Goltzman D, Henderson B, Loveridge N: Cytochemical bioassay of parathyroid hormone: characteristics of the assay and analysis of circulating hormonal forms. J Clin Invest 1980; 65: 1309-1317. (Pubitemid 10122372)
17. Bergström J, Wehle B: No change in corrected beta 2-microglobulin concentration after cuprophane haemodialysis. Lancet 1987; 1: 628-629. (Pubitemid 17024248)
18. Falkenhagen DTS, Brandi M: Correlation between activated clotting time and ionized calcium in regular dialysis treatment patients (poster). EDTA 2011.
19. Cheng YL, Yu AW, Tsang KY, et al: Anticoagulation during haemodialysis using a citrate- enriched dialysate: a feasibility study. Nephrol Dial Transplant 2011; 26: 641-646.
20. Ahmad S, Callan R, Cole J, et al: Increased dialyzer reuse with citrate dialysate. Hemodial Int 2005; 9: 264-267. (Pubitemid 41131074)